Ken Griffin’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$372M Sell
13,044,300
-6,038,400
-32% -$161M 0.04% 331
2026
Q2
$460M Buy
19,082,700
+7,028,800
+58% +$184M 0.05% 260
2026
Q1
$338M Sell
12,053,900
-6,876,000
-36% -$183M 0.05% 277
2025
Q4
$471M Buy
18,929,900
+4,429,400
+31% +$112M 0.07% 202
2025
Q3
$369M Sell
14,500,500
-1,476,700
-9% -$36.4M 0.06% 266
2025
Q2
$387M Sell
15,977,200
-3,559,300
-18% -$83M 0.07% 210
2025
Q1
$495M Buy
19,536,500
+1,204,000
+7% +$31.5M 0.09% 130
2024
Q4
$486M Sell
18,332,500
-6,494,100
-26% -$176M 0.08% 150
2024
Q3
$718M Sell
24,826,600
-4,764,000
-16% -$139M 0.14% 86
2024
Q2
$828M Buy
29,590,600
+1,022,900
+4% +$28.2M 0.17% 74
2024
Q1
$793M Buy
28,567,700
+7,386,400
+35% +$205M 0.15% 75
2023
Q4
$610M Buy
21,181,300
+2,295,400
+12% +$69.4M 0.12% 89
2023
Q3
$626M Buy
18,885,900
+1,480,400
+9% +$52.4M 0.13% 74
2023
Q2
$638M Buy
17,405,500
+9,277,000
+114% +$361M 0.13% 74
2023
Q1
$332M Sell
8,128,500
-5,171,300
-39% -$223M 0.07% 172
2022
Q4
$681M Buy
13,299,800
+5,719,400
+75% +$274M 0.16% 70
2022
Q3
$332M Buy
7,580,400
+203,300
+3% +$9.9M 0.08% 165
2022
Q2
$387M Sell
7,377,100
-2,537,400
-26% -$129M 0.1% 123
2022
Q1
$513M Buy
9,914,500
+2,031,300
+26% +$105M 0.11% 104
2021
Q4
$466M Sell
7,883,200
-2,684,800
-25% -$133M 0.1% 123
2021
Q3
$455M Buy
10,568,000
+2,717,100
+35% +$120M 0.09% 134
2021
Q2
$307M Sell
7,850,900
-4,451,000
-36% -$173M 0.07% 191
2021
Q1
$446M Sell
12,301,900
-365,100
-3% -$13M 0.11% 102
2020
Q4
$466M Buy
12,667,000
+6,267,200
+98% +$230M 0.12% 96
2020
Q3
$235M Buy
6,399,800
+2,351,500
+58% +$86.9M 0.07% 159
2020
Q2
$132M Buy
4,048,300
+244,900
+6% +$8.77M 0.05% 300
2020
Q1
$124M Buy
3,803,400
+134,600
+4% +$4.83M 0.06% 266
2019
Q4
$144M Sell
3,668,800
-716,600
-16% -$26.9M 0.06% 269
2019
Q3
$158M Buy
4,385,400
+1,950,600
+80% +$74.8M 0.07% 220
2019
Q2
$105M Sell
2,434,800
-267,000
-10% -$11.2M 0.05% 381
2019
Q1
$115M Buy
2,701,800
+971,900
+56% +$41M 0.06% 311
2018
Q4
$75.5M Buy
1,729,900
+503,200
+41% +$22M 0.04% 433
2018
Q3
$54.1M Sell
1,226,700
-174,800
-12% -$7.09M 0.02% 719
2018
Q2
$50.8M Buy
1,401,500
+333,600
+31% +$12M 0.03% 695
2018
Q1
$37.9M Sell
1,067,900
-160,000
-13% -$5.8M 0.02% 734
2017
Q4
$44.5M Buy
1,227,900
+138,600
+13% +$4.98M 0.03% 677
2017
Q3
$38.9M Sell
1,089,300
-24,100
-2% -$816K 0.03% 674
2017
Q2
$37.4M Sell
1,113,400
-509,400
-31% -$16.9M 0.03% 635
2017
Q1
$55.5M Sell
1,622,800
-742,400
-31% -$24.7M 0.05% 399
2016
Q4
$76.8M Buy
2,365,200
+893,100
+61% +$28.7M 0.08% 231
2016
Q3
$49.9M Sell
1,472,100
-787,900
-35% -$27.8M 0.05% 384
2016
Q2
$79.6M Buy
2,260,000
+386,800
+21% +$13M 0.09% 194
2016
Q1
$55.5M Buy
1,873,200
+1,036,700
+124% +$31.2M 0.07% 265
2015
Q4
$27M Sell
836,500
-216,200
-21% -$7.17M 0.03% 671
2015
Q3
$33.1M Buy
1,052,700
+279,300
+36% +$9.44M 0.03% 609
2015
Q2
$25.9M Buy
773,400
+186,100
+32% +$6.39M 0.02% 843
2015
Q1
$20.4M Sell
587,300
-227,800
-28% -$7.63M 0.02% 970
2014
Q4
$25.4M Buy
815,100
+116,800
+17% +$3.53M 0.03% 803
2014
Q3
$20.6M Sell
698,300
-71,500
-9% -$2.12M 0.02% 895
2014
Q2
$22.8M Sell
769,800
-214,100
-22% -$6.43M 0.03% 734
2014
Q1
$31.6M Sell
983,900
-54,300
-5% -$1.71M 0.04% 583
2013
Q4
$31.8M Buy
1,038,200
+210,000
+25% +$6.44M 0.04% 561
2013
Q3
$23.8M Buy
828,200
+66,500
+9% +$1.91M 0.04% 641
2013
Q2
$21.3M Hold
761,700
– – 0.04% 629

Other funds holding PFE

Ken Griffin's PFE Position: Q3 2026 in Review

Ken Griffin reduced its Pfizer (PFE) stake by 23% in Q3 2026, selling an estimated $38.6M and leaving 4,741,501 shares worth $135M. The position accounts for 0.02% of the portfolio, ranked #795.

Ken Griffin first reported a position in PFE in Q2 2013 and has held it in 54 quarters since. The position peaked at $571M in Q2 2024. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Ken Griffin held 4,741,501 shares of Pfizer worth $135M as of Q3 2026.
  • Ken Griffin sold 1,449,685 Pfizer shares in Q3 2026, an estimated $38.6M.
  • Pfizer made up 0.02% of Ken Griffin's portfolio in Q3 2026, its #795 holding.
  • Ken Griffin first reported a position in Pfizer in Q2 2013 and has held it in 54 quarters since.
  • Ken Griffin's Pfizer position peaked at $571M in Q2 2024.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.